Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes. Founded in 2018, Ansa Biotechnologies is backed by investors that include Horizons Ventures, Mubadala Capital | Ventures US, Fifty Years, and Humboldt Fund and is headquartered in Berkeley.
FOUNDED:
2018
INDUSTRY:
Biotechnology, Life Science, Therapeutics
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
